Elevated serum levels of interleukin-17A in children with autism

Journal of Neuroinflammation

Volumn 9, Issue , 2012, Pages

  AL Ayadhi, Laila Y ^a   Mostafa, Gehan A ^a,b,c  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b AIN SHAMS UNIVERSITY   (Egypt)

^c NONE   (Egypt)

Author keywords

Autism; Autoimmunity; Childhood autism rating scale; IL 17A; T helper 17

Indexed keywords

INTERLEUKIN 17;

ARTICLE; AUTISM; CHILD; CHILD HEALTH; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; NERVOUS SYSTEM INFLAMMATION; PRESCHOOL CHILD; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; SCHOOL CHILD;

EID: 84863100133     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-9-158     Document Type: Article

References (59)

1. Dong C. Genetic controls of Th17 cell differentiation and plasticity. Exp Mol Med 2011, 43(1):1-6. 10.3858/emm.2011.43.1.007, 3041933, 21270506.
2. Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM, et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005, 6:1123-1132. 10.1038/ni1254, 16200070.
3. Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang YH, et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 2005, 6(11):1133-1141. 10.1038/ni1261, 1618871, 16200068.
4. Weaver CT, Harrington LE, Mangan PR, Gavrieli M, Murphy KM. Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity 2006, 24:677-688. 10.1016/j.immuni.2006.06.002, 16782025.
5. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006, 441:235-238. 10.1038/nature04753, 16648838.
6. Schmidt-Weber CB, Akdis M, Akdis CA. TH17 cells in the big picture of immunology. J Allergy Clin Immunol 2007, 120:247-254. 10.1016/j.jaci.2007.06.039, 17666214.
7. Steinman L. A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. Nat Med 2007, 13(2):139-145. 10.1038/nm1551, 17290272.
8. Vautier S, Sousa Mda G, Brown GD. C-type lectins, fungi and Th17 responses. Cytokine Growth Factor Rev 2010, 21(6):405-412. 10.1016/j.cytogfr.2010.10.001, 3001956, 21075040.
9. Ouyang W, Kolls JK, Zheng Y. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 2008, 28:454-467. 10.1016/j.immuni.2008.03.004, 18400188.
10. Shinohara ML, Kim JH, Garcia VA, Cantor H. Engagement of the type I interferon receptor on dendritic cells inhibits T helper 17 cell development: role of intracellular osteopontin. Immunity 2008, 29(1):68-78. 10.1016/j.immuni.2008.05.008, 2625293, 18619869.
11. Chen M, Chen G, Nie H, Zhang X, Niu X, Zang YC, et al. Regulatory effects of IFN-beta on production of osteopontin and IL-17 by CD4+ T Cells in MS. Eur J Immunol 2009, 39(9):2525-2536. 10.1002/eji.200838879, 19670379.
12. Singh VK, Warren RP, Odell JD, Warren WL, Cole P. Antibodies to myelin basic protein in children with autistic behavior. Brain Behav Immun 1993, 7(1):97-103. 10.1006/brbi.1993.1010, 7682457.
13. Singh VK, Warren RP, Averett R, Ghaziuddin M. Circulating autoantibodies to neuronal and glial filament proteins in autism. Pediatr Neurol 1997, 17(1):88-90. 10.1016/S0887-8994(97)00045-3, 9308986.
14. Singh VK, Lin SX, Yang VC. Serological association of measles virus and human herpesvirus-6 with brain autoantibodies in autism. Clin Immunol Immunopathol 1998, 89(1):105-108. 10.1006/clin.1998.4588, 9756729.
15. Mostafa GA, El-Sayed ZA, Abd El Aziz MM, El-Sayed MF. Serum anti-myelin-associated glycoprotein antibodies in Egyptian autistic children. J Child Neurol 2008, 23:1413-1418. 10.1177/0883073808319321, 19073846.
16. Mostafa GA, Al-Ayadhi LY. Increased serum levels of anti-ganglioside M1 auto-antibodies in autistic children: relation to the disease severity. J Neuroinflammation 2011, 8:39. 10.1186/1742-2094-8-39, 3104945, 21513576.
17. Mostafa GA, Al-Ayadhi LY. The possible link between the elevated serum levels of neurokinin A and anti-ribosomal P protein antibodies in children with autism. J Neuroinflammation 2011, 8:180. 10.1186/1742-2094-8-180, 3261830, 22189180.
18. Al-Ayadhi LY, Mostafa GA. A lack of association between elevated serum levels of S100B protein and autoimmunity in autistic children. J Neuroinflammation 2012, 9(1):54. [Epub ahead of print], 10.1186/1742-2094-9-54, 3359166, 22420334.
19. Comi AM, Zimmerman AW, Frye VH, Law PA, Peeden JN. Familial clustering of autoimmune disorders and evaluation of medical risk factors in autism. J Child Neurol 1999, 14:388-394. 10.1177/088307389901400608, 10385847.
20. Sweeten TL, Bowyer SL, Posey DJ, Halberstadt GM, McDougle CJ. Increased prevalence of familial autoimmunity in probands with pervasive developmental disorders. Pediatrics 2003, 112(5):420-424.
21. Atladóttir HO, Pedersen MG, Thorsen P, Mortensen PB, Deleuran B, Eaton WW, et al. Association of Family History of autoimmune diseases and autism spectrum disorders. Pediatrics 1999, 124(2):687-694.
22. Mostafa GA, Kitchener N. Serum anti-nuclear antibodies as a marker of autoimmunity in Egyptian autistic children. Pediatr Neurol 2009, 40:107-112. 10.1016/j.pediatrneurol.2008.10.017, 19135624.
23. Mostafa GA, Shehab A. The link of C4B null allele to autism and to a family history of autoimmunity in Egyptian autistic children. J Neuroimmunol 2010, 223:115-119. 10.1016/j.jneuroim.2010.03.025, 20452682.
24. Croen LA, Grether JK, Yoshida CK, Odouli R, Van de Water J. Maternal autoimmune diseases, asthma and allergies, and childhood autism spectrum disorders.: a case-control study. Arch Pediatr Adolesc Med 2005, 159(2):151-157. 10.1001/archpedi.159.2.151, 15699309.
25. Mostafa GA, Al Shehab A, Fouad NR. Increased frequency of CD4+CD25high regulatoryT cells in the peripheral blood of Egyptian children with autism. J Child Neurol 2010, 25:328-335. 10.1177/0883073809339393, 19713552.
26. Mostafa GA, El-Hadidi ES, Hewedi DH, Abdou MM. Oxidative stress in Egyptian children with autism: relation to autoimmunity. J Neuroimmunol 2010, 219:114-118. 10.1016/j.jneuroim.2009.12.003, 20036015.
27. Warren RP, Singh VK, Cole P, Odell JD, Pingree CB, Warren WL, White E. Increased frequency of the null allele at the complement C4b locus in autism. Clin Exp Immunol 1991, 83:438-440. 1535320, 2004485.
28. Odell D, Maciulis A, Cutler A, Warren L, McMahon WM, Coon H, et al. Confirmation of the association of C4B null allele in autism. Human Immunol 2005, 6(2):140-145.
29. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 1994, American Psychiatric Association, Washington DC, 4, American Psychiatric Association.
30. Schopler E, Reichler RJ, Renner BR. The Childhood Autism Rating Scale (CARS), for Diagnostic Screening and Classification in Autism 1986, Irvington, New York, NY.
31. Hueber W, Patel DD, Dryja T, Wright AM, Koroleva I, Bruin G, et al. Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis. Sci Transl Med 2010, 2(52):52-72.
32. Mangan PR, Harrington LE, O'Quinn DB, Helms WS, Bullard DC, Elson CO, et al. Transforming growth factor-beta induces development of the T(H) 17 lineage. Nature 2006, 441:231-234. 10.1038/nature04754, 16648837.
33. Onore C, Enstrom A, Krakowiak P, Hertz-Picciotto I, Hansen R, Van de Water J, et al. Decreased cellular IL-23 but not IL-17 production in children with autism spectrum disorders. J Neuroimmunol 2009, 216(1-2):126-129. 2981175, 19800697.
34. Suzuki K, Matsuzaki H, Iwata K, Kameno Y, Shimmura C, Kawai S, et al. Plasma cytokine profiles in subjects with high-functioning autism spectrum disorders. PLoS One 2011, 6(5):e20470. 10.1371/journal.pone.0020470, 3103577, 21647375.
35. Garrett-Sinha LA, John S, Gaffen SL. IL-17 and the Th17 lineage in systemic lupus erythematosus. Curr Opin Rheumatol 2008, 20:519-525. 10.1097/BOR.0b013e328304b6b5, 18698171.
36. Nguyen CQ, Hu MH, Li Y, Stewart C, Peck AB. Salivary gland tissue expression of interleukin-23 and interleukin-17 in Sjogren's syndrome: findings in humans and mice. Arthritis Rheum 2008, 58:734-743. 10.1002/art.23214, 2850059, 18311793.
37. Sakai A, Sugawara Y, Kuroishi T, Sasano T, Sugawara S. Identification of IL-18 and Th17 cells in salivary glands of patients with Sjogren's syndrome, and amplification of IL-17-mediated secretion of inflammatory cytokines from salivary gland cells by IL-18. J Immunol 2008, 181:2898-2906.
38. Tesmer LA, Lundy SK, Sarkar S, Fox DA. Th17 cells in human disease. Immunol Rev 2008, 223:87-113. 10.1111/j.1600-065X.2008.00628.x, 3299089, 18613831.
39. Jadidi-Niaragh F, Mirshafiey A. Th17 cell, the new player of neuroinflammatory process in multiple sclerosis. Scand J Immunol 2011, 74(1):1-13. 10.1111/j.1365-3083.2011.02536.x, 21338381.
40. Robinson DS, O'Garra A. Further checkpoints in Th1 development. Immunity 2002, 16:755-758. 10.1016/S1074-7613(02)00331-X, 12121657.
41. van Beelen AJ, Zelinkova Z, Taanman-Kueter EW, Muller FJ, Hommes DW, Zaat SA, et al. Stimulation of the intracellular bacterial sensor NOD2 programs dendritic cells to promote interleukin-17 production in human memory T cells. Immunity 2007, 27:660-669. 10.1016/j.immuni.2007.08.013, 17919942.
42. Acosta-Rodriguez EV, Napolitani G, Lanzavecchia A, Sallusto F. Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat Immunol 2007, 8:942-949.
43. Volpe E, Servant N, Zollinger R, Bogiatzi SI, Hupé P, Barillot E, et al. A critical function for transforming growth factor-beta, interleukin 23 and proinflammatory cytokines in driving and modulating human T(H)-17 responses. Nat Immunol 2008, 9:650-657.
44. Ivanov II, McKenzie BS, Zhou L, Tadokoro CE, Lepelley A, Lafaille JJ, et al. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 2006, 126:1121-1133. 10.1016/j.cell.2006.07.035, 16990136.
45. Yang XO, Pappu BP, Nurieva R, Akimzhanov A, Kang HS, Chung Y, et al. T helper 17 lineage differentiation is programmed by orphan nuclear receptors RORalpha and RORgamma. Immunity 2008, 28:29-39. 10.1016/j.immuni.2007.11.016, 2587175, 18164222.
46. Gerosa F, Baldani-Guerra B, Lyakh LA, Batoni G, Esin S, Winkler-Pickett RT, et al. Differential regulation of interleukin 12 and interleukin 23 production in human dendritic cells. J Exp Med 2008, 205:1447-1461. 10.1084/jem.20071450, 2413040, 18490488.
47. Khader SA, Gaffen SL, Kolls JK. Th17 cells at the crossroads of innate and adaptive immunity against infectious diseases at the mucosa. Mucosal Immunol 2009, 2:403-411. 10.1038/mi.2009.100, 2811522, 19587639.
48. Vignali DA, Collison LW, Workman CJ. How regulatory T cells work. Nat Rev Immunol 2008, 8:523-532. 10.1038/nri2343, 2665249, 18566595.
49. Bettelli E, Korn T, Oukka M, Kuchroo VK. Induction and effector functions of T(H)17 cells. Nature 2008, 453:1051-1057. 10.1038/nature07036, 18563156.
50. Murugaiyan G, Mittal A, Weiner HL. Increased osteopontin expression in dendritic cells amplifies IL-17 production by CD4+ T cells in experimental autoimmune encephalomyelitis and in multiple sclerosis. J Immunol 2008, 181(11):7480-7488. 2653058, 19017937.
51. Al-Ayadhi LY, Mostafa GA. Increased serum osteopontin levels in autistic children: Relation to the disease severity. Brain Behav Immun 2011, 25(7):1393-1398. 10.1016/j.bbi.2011.04.006, 21521652.
52. Cohly HH, Panja A. Immunological findings in autism. Int Rev Neurobiol 2005, 71:317-341.
53. Al-Ayadhi LY, Mostafa GA. Low plasma progranulin levels in children with autism. J Neuroinflammation 2011, 8(1):111. 10.1186/1742-2094-8-111, 3182917, 21892962.
54. Vojdani A, Campbell AW, Anyanwu E, Kashanian A, Bock K, Vojdani E. Antibodies to neuron-specific antigens in children with autism: possible cross-reaction with encephalitogenic proteins from milk, Chlamydia pneumoniae and Streptococcus group A. J Neuroimmunol 2002, 129(1-2):168-177.
55. Mostafa GA, Al-Ayadhi LY. A lack of association between hyperserotonemia and the increased frequency of serum anti-myelin basic protein auto-antibodies in autistic children. J Neuroinflammation 2011, 8:71. 10.1186/1742-2094-8-71, 3142225, 21696608.
56. Singh VK. Plasma increase of interleukin-12 and interferon-gamm. Pathological significance in autism. J Neuroimmunol 1996, 66(1-2):143-145.
57. Ashwood P, Krakowiak P, Hertz-Picciotto I, Hansen R, Pessah IN, Van de Water J. Altered T cell responses in children with autism. Brain Behav Immun 2011, 25(5):840-849. 10.1016/j.bbi.2010.09.002, 3039713, 20833247.
58. Ishigame H, Kakuta S, Nagai T, Kadoki M, Nambu A, Komiyama Y, et al. Differential roles of interleukin-17A and -17F in host defense against mucoepithelial bacterial infection and allergic responses. Immunity 2009, 30:108-119. 10.1016/j.immuni.2008.11.009, 19144317.
59. Lin Y, Ritchea S, Logar A, Slight S, Messmer M, Rangel-Moreno J, et al. Interleukin-17 is required for T helper 1 cell immunity and host resistance to the intracellular pathogen Francisella tularensis. Immunity 2009, 31:799-810. 10.1016/j.immuni.2009.08.025, 2789998, 19853481.